Literature DB >> 34279042

Variants on the UBE2L3/YDJC Autoimmune Disease Risk Haplotype Increase UBE2L3 Expression by Modulating CCCTC-Binding Factor and YY1 Binding.

Jaanam Gopalakrishnan1, Kandice L Tessneer2, Yao Fu2, Satish Pasula2, Richard C Pelikan2, Jennifer A Kelly2, Graham B Wiley2, Patrick M Gaffney1.   

Abstract

OBJECTIVE: Genetic variants spanning UBE2L3 are associated with increased expression of the UBE2L3-encoded E2 ubiquitin-conjugating enzyme H7 (UbcH7), which facilitates activation of proinflammatory NF-κB signaling and susceptibility to autoimmune diseases. We undertook this study to delineate how genetic variants carried on the UBE2L3/YDJC autoimmune risk haplotype function to drive hypermorphic UBE2L3 expression.
METHODS: We used bioinformatic analyses, electrophoretic mobility shift assays, and luciferase reporter assays to identify and functionally characterize allele-specific effects of risk variants positioned in chromatin accessible regions of immune cells. Chromatin conformation capture with quantitative polymerase chain reaction (3C-qPCR), chromatin immunoprecipitation (ChIP)-qPCR, and small interfering RNA (siRNA) knockdown assays were performed on patient-derived Epstein-Barr virus-transformed B cells homozygous for the UBE2L3/YDJC nonrisk or risk haplotype to determine if the risk haplotype increases UBE2L3 expression by altering the regulatory chromatin architecture in the region.
RESULTS: Of the 7 prioritized variants, 5 demonstrated allele-specific increases in nuclear protein binding affinity and regulatory activity. High-throughput sequencing of chromosome conformation capture coupled with ChIP (HiChIP) and 3C-qPCR uncovered a long-range interaction between the UBE2L3 promoter (rs140490, rs140491, rs11089620) and the downstream YDJC promoter (rs3747093) that was strengthened in the presence of the UBE2L3/YDJC risk haplotype, and correlated with the loss of CCCTC-binding factor (CTCF) and gain of YY1 binding at the risk alleles. Depleting YY1 by siRNA disrupted the long-range interaction between the 2 promoters and reduced UBE2L3 expression.
CONCLUSION: The UBE2L3/YDJC autoimmune risk haplotype increases UBE2L3 expression through strengthening a YY1-mediated interaction between the UBE2L3 and YDJC promoters.
© 2021, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34279042      PMCID: PMC8712360          DOI: 10.1002/art.41925

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  41 in total

1.  Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.

Authors:  Eli A Stahl; Soumya Raychaudhuri; Elaine F Remmers; Gang Xie; Stephen Eyre; Brian P Thomson; Yonghong Li; Fina A S Kurreeman; Alexandra Zhernakova; Anne Hinks; Candace Guiducci; Robert Chen; Lars Alfredsson; Christopher I Amos; Kristin G Ardlie; Anne Barton; John Bowes; Elisabeth Brouwer; Noel P Burtt; Joseph J Catanese; Jonathan Coblyn; Marieke J H Coenen; Karen H Costenbader; Lindsey A Criswell; J Bart A Crusius; Jing Cui; Paul I W de Bakker; Philip L De Jager; Bo Ding; Paul Emery; Edward Flynn; Pille Harrison; Lynne J Hocking; Tom W J Huizinga; Daniel L Kastner; Xiayi Ke; Annette T Lee; Xiangdong Liu; Paul Martin; Ann W Morgan; Leonid Padyukov; Marcel D Posthumus; Timothy R D J Radstake; David M Reid; Mark Seielstad; Michael F Seldin; Nancy A Shadick; Sophia Steer; Paul P Tak; Wendy Thomson; Annette H M van der Helm-van Mil; Irene E van der Horst-Bruinsma; C Ellen van der Schoot; Piet L C M van Riel; Michael E Weinblatt; Anthony G Wilson; Gert Jan Wolbink; B Paul Wordsworth; Cisca Wijmenga; Elizabeth W Karlson; Rene E M Toes; Niek de Vries; Ann B Begovich; Jane Worthington; Katherine A Siminovitch; Peter K Gregersen; Lars Klareskog; Robert M Plenge
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

2.  A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus.

Authors:  S Wang; I Adrianto; G B Wiley; C J Lessard; J A Kelly; A J Adler; S B Glenn; A H Williams; J T Ziegler; M E Comeau; M C Marion; B E Wakeland; C Liang; K M Kaufman; J M Guthridge; M E Alarcón-Riquelme; G S Alarcón; J-M Anaya; S-C Bae; J-H Kim; Y B Joo; S A Boackle; E E Brown; M A Petri; R Ramsey-Goldman; J D Reveille; L M Vilá; L A Criswell; J C Edberg; B I Freedman; G S Gilkeson; C O Jacob; J A James; D L Kamen; R P Kimberly; J Martin; J T Merrill; T B Niewold; B A Pons-Estel; R H Scofield; A M Stevens; B P Tsao; T J Vyse; C D Langefeld; J B Harley; E K Wakeland; K L Moser; C G Montgomery; P M Gaffney
Journal:  Genes Immun       Date:  2012-04-05       Impact factor: 2.676

3.  hichipper: a preprocessing pipeline for calling DNA loops from HiChIP data.

Authors:  Caleb A Lareau; Martin J Aryee
Journal:  Nat Methods       Date:  2018-02-28       Impact factor: 28.547

4.  YY1 Is a Structural Regulator of Enhancer-Promoter Loops.

Authors:  Abraham S Weintraub; Charles H Li; Alicia V Zamudio; Alla A Sigova; Nancy M Hannett; Daniel S Day; Brian J Abraham; Malkiel A Cohen; Behnam Nabet; Dennis L Buckley; Yang Eric Guo; Denes Hnisz; Rudolf Jaenisch; James E Bradner; Nathanael S Gray; Richard A Young
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

5.  Linear polyubiquitin chains: a new modifier involved in NFκB activation and chronic inflammation, including dermatitis.

Authors:  Kazuhiro Iwai
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

6.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

Authors:  Lam C Tsoi; Sarah L Spain; Jo Knight; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jun Ding; Yanming Li; Trilokraj Tejasvi; Johann E Gudjonsson; Hyun M Kang; Michael H Allen; Ross McManus; Giuseppe Novelli; Lena Samuelsson; Joost Schalkwijk; Mona Ståhle; A David Burden; Catherine H Smith; Michael J Cork; Xavier Estivill; Anne M Bowcock; Gerald G Krueger; Wolfgang Weger; Jane Worthington; Rachid Tazi-Ahnini; Frank O Nestle; Adrian Hayday; Per Hoffmann; Juliane Winkelmann; Cisca Wijmenga; Cordelia Langford; Sarah Edkins; Robert Andrews; Hannah Blackburn; Amy Strange; Gavin Band; Richard D Pearson; Damjan Vukcevic; Chris C A Spencer; Panos Deloukas; Ulrich Mrowietz; Stefan Schreiber; Stephan Weidinger; Sulev Koks; Külli Kingo; Tonu Esko; Andres Metspalu; Henry W Lim; John J Voorhees; Michael Weichenthal; H Erich Wichmann; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Christopher E M Griffiths; Andre Reis; Juha Kere; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; James T Elder; Richard C Trembath
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

7.  Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes.

Authors:  Kimberly E Taylor; Sharon A Chung; Robert R Graham; Ward A Ortmann; Annette T Lee; Carl D Langefeld; Chaim O Jacob; M Ilyas Kamboh; Marta E Alarcón-Riquelme; Betty P Tsao; Kathy L Moser; Patrick M Gaffney; John B Harley; Michelle Petri; Susan Manzi; Peter K Gregersen; Timothy W Behrens; Lindsey A Criswell
Journal:  PLoS Genet       Date:  2011-02-17       Impact factor: 5.917

8.  Risk variants disrupting enhancers of TH1 and TREG cells in type 1 diabetes.

Authors:  Peng Gao; Yasin Uzun; Bing He; Sarah E Salamati; Julie K M Coffey; Eva Tsalikian; Kai Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

9.  Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.

Authors:  M Ryan Corces; Jason D Buenrostro; Beijing Wu; Peyton G Greenside; Steven M Chan; Julie L Koenig; Michael P Snyder; Jonathan K Pritchard; Anshul Kundaje; William J Greenleaf; Ravindra Majeti; Howard Y Chang
Journal:  Nat Genet       Date:  2016-08-15       Impact factor: 38.330

10.  Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks.

Authors:  Richard C Pelikan; Jennifer A Kelly; Yao Fu; Caleb A Lareau; Kandice L Tessneer; Graham B Wiley; Mandi M Wiley; Stuart B Glenn; John B Harley; Joel M Guthridge; Judith A James; Martin J Aryee; Courtney Montgomery; Patrick M Gaffney
Journal:  Nat Commun       Date:  2018-07-25       Impact factor: 17.694

View more
  1 in total

1.  Systemic lupus erythematosus variants modulate the function of an enhancer upstream of TNFAIP3.

Authors:  Satish Pasula; Jaanam Gopalakrishnan; Yao Fu; Kandice L Tessneer; Mandi M Wiley; Richard C Pelikan; Jennifer A Kelly; Patrick M Gaffney
Journal:  Front Genet       Date:  2022-09-19       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.